In IBD, PD-L1 expression on intestinal epithelial and immune cells may modulate the local immune milieu, potentially sustaining chronic inflammation (Chulkina et al., 2020; Nguyen et al., 2022). The gene discussed is CD274; the disease is inflammatory bowel disease.